Buy Semax 5mg Peptide

Direct Sourcing Overview: Purchasing Semax 5mg for Research

To buy Semax 5mg peptide for laboratory research, investigators require verified purity, strict batch traceability, and comprehensive analytical documentation. PX1 Research supplies high-grade Semax 5mg (ACTH 4-10 heptapeptide analog) manufactured in US-based GMP-compliant facilities. Every lot undergoes independent RP-HPLC and mass spectrometry testing to ensure ≥98% purity alongside rigorous endotoxin verification for reliable experimental reproducibility.

When procuring experimental compounds for analytical assays or animal models, acquiring fully validated reagents is paramount. PX1 Research provides institutional laboratories and qualified researchers direct access to premium Semax 5mg alongside our broader catalog of all research peptides. Each vial contains 5 milligrams of sterile-filtered, lyophilized peptide prepared under cleanroom conditions to prevent degradation and cross-contamination.

Chemical Profile and Molecular Specifications of Semax

Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH), specifically the sequence ACTH(4-10), fused with a C-terminal tripeptide Pro-Gly-Pro. Its sequence is defined as Met-Glu-His-Phe-Pro-Gly-Pro. The addition of the C-terminal tripeptide structural motif significantly alters the enzymatic stability of the peptide compared to native endogenous fragments, extending its half-life in extracellular environments during in vitro and ex vivo testing.

The molecular formula of Semax is C37H51N9O10S, possessing a calculated molecular mass of approximately 810.9 g/mol. In solid state, the material presents as a white to off-white lyophilized cake or powder. Its structural design allows it to retain neurotropic and regulatory activity while lacking the systemic glucocorticoid-stimulating effects associated with full-length ACTH sequence signaling in adrenal tissues.

Preclinical Mechanisms of Action: BDNF, TrkB, and Neuroplasticity

In preclinical literature, Semax has been evaluated extensively for its influence on neurotrophin expression and synaptic plasticity pathways. Animal model investigations demonstrate that administration of Semax rapidly upregulates expression of Brain-Derived Neurotrophic Factor (BDNF) and its corresponding receptor, Tropomyosin receptor kinase B (TrkB), within the hippocampus and basal forebrain structures.

Preclinical studies suggest that this elevation of BDNF protein levels and mRNA transcripts plays a critical role in neuroprotective signaling cascades. In vitro assays using cultured neuronal networks demonstrate enhanced neurite outgrowth, dendritic spine density preservation, and resistance to metabolic stress following exposure to Semax. Researchers frequently utilize Semax to study transcription factor activation downstream of TrkB, including CREB and MAPK/ERK pathways.

Beyond BDNF modulation, Semax interacts with central melanocortin receptors (MC4 and MC5) as a selective agonist or partial agonist depending on target tissue context. In vitro binding studies show low-micromolar affinity for melanocortin targets, offering a unique biochemical pathway through which neuroinflammatory signaling, microglial activation, and central neuropeptide degradation kinetics can be observed. Comprehensive analysis of these regulatory networks is detailed across our research library hub.

Investigational Domains: Cerebrovascular and Neuroprotective Preclinical Models

The scientific literature surrounding Semax spans several decades of preclinical investigation, predominantly focusing on ischemic injury, hypoxia, and neurodegenerative stress models:

1. Ischemic and Hypoxic Stress Models: In rodent models of permanent or transient middle cerebral artery occlusion (MCAO), Semax administration has been observed to attenuate cerebral infarction volume, reduce edema, and limit post-ischemic apoptosis within peri-infarct cortical regions.

2. Glutamatergic Excitotoxicity: In vitro neuronal assays exposed to toxic concentrations of L-glutamate display reduced LDH release and improved mitochondrial membrane potential when pre-incubated or co-incubated with Semax, suggesting direct cellular neuroprotection against excitotoxic signaling cascades.

3. Cerebrovascular Regulation: Preclinical measurements of local cerebral blood flow (CBF) in rodent models show that Semax influences microvascular tone and endothelial nitric oxide synthase (eNOS) transcription, providing a framework for examining vascular responses to brain injury.

4. Enkephalin Degradation Modulation: In vitro enzymatic assays demonstrate that Semax inhibits enkephalin-degrading enzymes (such as carboxypeptidases and enkephalinases), thereby prolonging the functional half-life of endogenous opioid peptides in central nervous system preparations.

Comparative Analysis: Semax vs. Selank and Modified Analogs

In neurobiological research, Semax is frequently analyzed alongside other regulatory synthetic peptides to compare structural stability, receptor selectivity, and neurotrophic efficacy. Understanding these distinctions helps research teams select the exact analog required for their specific experimental paradigms.

When evaluating synthetic neuropeptides, investigators often compare Semax 5mg to Selank 5mg, another heptapeptide derived from the endogenous immunomodulatory peptide tuftsin (Thr-Lys-Pro-Arg-Pro-Gly-Pro). While Semax selectively targets melanocortin signaling, BDNF upregulation, and vascular microprotection, Selank exhibits prominent immunomodulatory and GABAergic modulating characteristics in rodent paradigms. Furthermore, advanced structural modifications have led to compounds like N-Acetyl Semax Amidate, where N-terminal acetylation and C-terminal amidation are introduced to enhance resistance against enzymatic cleavage by aminopeptidases and carboxypeptidases in tissue homogeneous assays. Researchers looking into tissue recovery models also evaluate non-neurological peptide signaling pathways using compounds such as BPC-157 5mg to contrast central neuropeptide activity with systemic extracellular matrix repair mechanisms.

Laboratory Reconstitution Protocol and Buffer Selection

Proper handling and reconstitution protocols are vital to maintain the molecular stability and structural conformation of Semax 5mg during laboratory procedures. Standardized cleanroom techniques must be strictly maintained.

1. Solvent Choice: For in vitro cell culture applications or in vivo animal dosing studies, lyophilized Semax should be reconstituted using sterile, non-pyrogenic Bacteriostatic Water (0.9% benzyl alcohol) or sterile 0.9% Sodium Chloride Injection, USP. The choice depends on whether immediate single-use assays or multi-entry vessel sampling is required.

2. Reconstitution Technique: Allow the lyophilized vial to equilibrate to room temperature before introducing solvent. Gently inject the calculated volume of diluent along the inner glass wall of the vial to avoid high-shear force on the peptide matrix. Swirl gently in a circular motion; do not shake or vortex vigorously, as physical agitation can induce peptide aggregation or denaturation.

3. Concentration Calculation: Reconstituting 5mg of Semax powder with 2.5 mL of solvent yields a working stock concentration of 2.0 mg/mL (2000 mcg/mL). Adding 5.0 mL of solvent yields a standard 1.0 mg/mL stock concentration, facilitating precise aliquoting for analytical equipment or micro-dosing delivery systems in animal models.

Storage, Thermal Stability, and Decay Kinetics

Unreconstituted, lyophilized Semax 5mg maintains structural integrity when stored at -20°C to -80°C in a desiccated environment protected from direct light exposure. Under these conditions, the peptide exhibits long-term stability with minimal chemical degradation over 24 months.

Short-term ambient temperature exposure during transit (up to 3–5 days) does not compromise the molecular integrity of lyophilized Semax, as proven by stress-stability testing. Upon arrival, vials should immediately be placed into cold storage.

Once reconstituted into solution, Semax stock solutions should be stored at 2°C to 8°C (36°F to 46°F) and utilized within 21 to 30 days. For longer storage of liquid stock solutions, prepare single-use sub-aliquots using polypropylene microtubes and freeze at -80°C to prevent repeated freeze-thaw cycles, which degrade peptide chains via ice-crystal shear stress.

Quality Verification: HPLC, Mass Spectrometry, and Endotoxin Testing

PX1 Research enforces strict quality control standards for every batch of Semax 5mg produced. Laboratory research integrity depends on chemical purity and complete absence of biological or chemical contaminants.

Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) is utilized to measure chemical purity and identify potential related peptide impurities. Every lot of PX1 Research Semax 5mg is guaranteed to meet or exceed ≥98.0% purity as calculated by total integrated peak area.

Electrospray Ionization Mass Spectrometry (ESI-MS) confirms the exact molecular weight and structural identity of the synthesized heptapeptide, verifying that no truncation or incomplete coupling occurred during solid-phase peptide synthesis (SPPS).

Additionally, bacterial endotoxin testing via Limulus Amebocyte Lysate (LAL) assay ensures endotoxin levels remain below strictly defined thresholds (<0.5 EU/mg). High endotoxin concentrations lead to non-specific inflammatory responses in cellular assays or animal research, skewing experimental results. Comprehensive lot-specific Certificates of Analysis (COA) are available to verified institutions and can be accessed through our wholesale and lab account setup.

PX1 Research Advantage: Domestic Manufacturing & Direct Supply

PX1 Research operates as a premier primary supplier of research peptides for academic institutions, biotechnology companies, and contract research organizations (CROs) across the United States. All products are manufactured in US-based, ISO 17025 accredited and GMP-compliant facilities.

By controlling the synthesis, purification, analytical testing, and cold-chain packaging processes domestically, PX1 Research eliminates supply chain volatility and overseas quality inconsistencies. Orders placed Monday through Friday ship same-day from fully stocked fulfillment centers in California and Arizona.

Every shipment of Semax 5mg includes full lot documentation, direct access to raw analytical data files upon request, and protective insulated packaging designed to maintain temperature stability during transit.